Serum levels of CXCL4 were found to be elevated in patients with viral hepatitis and fibrosis, while the expression of CXCL4 in the liver was downregulated by the platelet inhibitor aspirin in a rat fibrosis model [52,70]. This evidence concerns the gene PF4 and fibrosis.